Prohibition of Sixteen Fixed-Dose Combination Pharmaceutical Products by the Union Health Ministry
聯邦衛生部禁止十六款固定劑量組合藥品
Introduction
The Union Health Ministry has implemented an immediate ban on the production, commercialization, and distribution of sixteen fixed-dose combination (FDC) drugs within India.
聯邦衛生部已立即禁止在印度境內生產、商業化及分發十六種固定劑量組合（FDC）藥物。
Main Body
The regulatory action was executed under Section 26A of the Drugs and Cosmetics Act, 1940, following a multi-year review process initiated in compliance with mandates from the Supreme Court. The Drugs Technical Advisory Board (DTAB) convened an expert committee to evaluate the therapeutic rationality of various FDCs. In 2021, this committee determined that a subset of these combinations lacked sufficient peer-reviewed scientific evidence to justify their clinical utility.
此次監管行動是根據 1940 年《藥品與化妝品法》第 26A 條執行，是在遵循最高法院指令而展開的多年審查程序後採取。藥品技術諮詢委員會（DTAB）召集了一個專家委員會，以評估各種 FDC 的治療合理性。2021 年，該委員會判定其中部分組合缺乏足夠的同行評審科學證據，不足以證明其臨床用途。
Specific pharmacological objections were detailed across several therapeutic categories. Regarding antibiotic-based formulations, such as those pairing amoxicillin or cefuroxime with serratiopeptidase, the committee characterized the combinations as 'pharmacodynamically irrelevant,' noting a deficiency in clinical evidence for concurrent administration. Similarly, dicyclomine-based combinations were deemed unjustified due to the inherent anti-cholinergic properties of dicyclomine, which render the addition of clidinium bromide redundant. In the context of Type 2 diabetes management, the inclusion of chromium picolinate with gliclazide was found to be unsupported by national or international treatment guidelines. Furthermore, the combination of cefadroxil and probenecid was prohibited due to a lack of pharmacokinetic data regarding dose titration.
針對幾個治療類別提出了詳細的藥理反對意見。關於抗生素配方，例如將氨莫西林或 cefuroxime 與 serratiopeptidase 配合的藥物，委員會將這些組合定義為「藥理動力學上不相關」，並指出缺乏同時給藥的臨床證據。同樣地，基於 dicyclomine 的組合被認為是不合理的，因為 dicyclomine 具有固有的抗膽鹼特性，使得添加 clidinium bromide 變得多餘。在 2 型糖尿病管理方面，發現將 picolinate 鉻與 gliclazide 組合並不被國家或國際治療指南所支持。此外，cefadroxil 與 probenecid 的組合因缺乏關於劑量滴定的藥動學數據而被禁止。
Topical formulations featuring aloe vera and various oils or vitamins were also prohibited, as the committee found these products were insufficiently characterized and lacked scientific validation. Prior to the final prohibition, the DTAB sub-committee provided stakeholders and manufacturers an opportunity to submit supporting data via public notices. Following the submission of a final report on December 28, 2024, the Central Government concluded that the prohibition of these sixteen FDCs was necessary to mitigate patient risk and ensure the availability of scientifically validated medicines.
含有蘆薈及各種油脂或維生素的外用製劑也被禁止，因為委員會發現這些產品的特性描述不足且缺乏科學驗證。在最終禁止之前，DTAB 分委員會透過公開通知，為利益相關者和製造商提供了提交支持數據的機會。在 2024 年 12 月 28 日提交最終報告後，中央政府得出結論，禁止這十六款 FDC 對於降低患者風險並確保提供經科學驗證的藥品是必要的。
Conclusion
The manufacture and sale of the identified FDCs are now prohibited nationwide, with regulatory agencies directed to ensure strict compliance.
目前全國已禁止生產與銷售這些指定的 FDC，監管機構已被指示確保嚴格遵守。
Vocabulary Learning
The Architecture of 'Clinical Coldness': Mastering the Nominalized Passive
To move from B2 to C2, a student must stop merely describing actions and start constructing institutional authority. The provided text is a masterclass in Nominalization and Agentless Passivity, the linguistic bedrock of high-level regulatory, legal, and scientific discourse.
⚡ The C2 Pivot: From Action to Entity
B2 learners often rely on active verbs ("The committee decided that the drugs were not useful"). A C2 practitioner transforms the action into a noun phrase, stripping away the human element to create an aura of objective inevitability.
Contrast the Evolution:
- B2 (Active/Linear): The government banned these drugs because they didn't have enough evidence.
- C1 (Formal/Passive): These drugs were banned by the government due to a lack of evidence.
- C2 (Nominalized/Institutional): "The prohibition of these sixteen FDCs was necessary to mitigate patient risk..."
In the C2 version, "prohibition" is no longer something someone did; it is a conceptual entity that exists as a necessity. This is The Architecture of Clinical Coldness.
🔍 Deconstructing the 'Power Phrases'
Observe how the text employs specific collocations to bridge the gap between simple reporting and authoritative decree:
- "Therapeutic rationality" Instead of saying "whether the drug works," the text uses a noun-cluster that implies a rigorous, logical framework.
- "Pharmacodynamically irrelevant" The use of the adverbial prefix pharmaco- combined with a high-level adjective creates a precise, exclusionary boundary of meaning.
- "Insufficiently characterized" A classic C2 hedge. It doesn't say the products are bad, but that their characterization (the act of describing them) is insufficient.
🛠️ Syntactic Strategy: The 'Dense Core'
Notice the phrase: "...following a multi-year review process initiated in compliance with mandates from the Supreme Court."
This is a dense noun phrase. The core is "review process," but it is modified by a temporal adjective ("multi-year") and a participial phrase ("initiated in compliance with..."). To replicate this at C2, you must learn to stack modifiers around a central noun to compress complex legal histories into a single sentence fragment.